glutamate ionotropic receptor kainate type subunit 5
RGD ID:
2735
Description:
Enables identical protein binding activity; kainate selective glutamate receptor activity; and protein domain specific binding activity. Contributes to glutamate-gated receptor activity. Involved in several processes, including cellular response to glucose stimulus; positive regulation of neuron apoptotic process; and protein retention in ER lumen. Located in several cellular components, including dendrite; perikaryon; and terminal bouton. Part of ionotropic glutamate receptor complex. Is active in glutamatergic synapse; postsynaptic membrane; and presynaptic membrane. Biomarker of temporal lobe epilepsy. Human ortholog(s) of this gene implicated in chronic obstructive pulmonary disease. Orthologous to human GRIK5 (glutamate ionotropic receptor kainate type subunit 5); PARTICIPATES IN glutamate signaling pathway; INTERACTS WITH (+)-pilocarpine; 1-naphthyl isothiocyanate; acetamide.
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GRIK5 protein
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of GRIK5 mRNA
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of GRIK5 mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GRIK5 protein
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GRIK5 protein
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of GRIK5 mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GRIK5 protein
Celecoxib promotes the reaction [Kainic Acid results in decreased expression of GRIK5 mRNA] and PTGS2 affects the reaction [Kainic Acid results in decreased expression of GRIK5 mRNA]
Ultrastructural localisation and differential agonist-induced regulation of AMPA and kainate receptors present at the presynaptic active zone and postsynaptic density.
[Polymorphic Variants of Glutamate Receptor (GRIK5, GRIN2B) and Serotonin Receptor (HTR2A) Genes Are Associated with Chronic Obstructive Pulmonary Disease].
plays a role in frequency facilitation and induction of long-term potentiation (LTP) in mossy fiber pathways and in excitatory drives of inhibitory CA1 interneurons